Safety, Eligibility, and Who Should Consider Tirzepatide for Weight Loss Tirzepatide is prescribed off-label for weight loss in patients with obesity or overweight with comorbidities, typically under medical supervision
Effects of T2DM on the Digestive System Virtually all parts of the human digestive system, including the gastrointestinal tract, pancreas, and the liver are affected by diabetes
You should contact your GP or healthcare provider if: Severe or worsening pain that does not improve with simple analgesia or interferes significantly with daily activities Persistent symptoms lasting more than one to two weeks without improvement Muscle weakness or difficulty performing routine tasks such as climbing stairs or lifting objects Joint swelling, redness, or warmth , which may indicate inflammatory arthritis or infection Fever or signs of infection accompanying body aches, such as chills, sweating, or feeling generally unwell Dark-coloured urine or reduced urine output, which could suggest dehydration or, rarely, rhabdomyolysis (muscle breakdown) Chest pain, shortness of breath, or palpitations , which require urgent assessment to exclude cardiac causes Severe right upper abdominal pain, fever, or yellowing of the skin/eyes , which may indicate gallbladder disease (a recognised risk with GLP-1 receptor agonists and rapid weight loss) [2] New or worsening visual symptoms if you have pre-existing diabetic retinopathy, as rapid improvement in blood glucose can sometimes temporarily worsen retinopathy [2] Seek immediate medical attention (call 999 or attend A&E) if you experience: Severe abdominal pain, particularly if accompanied by persistent vomiting, which may indicate pancreatitisa rare but serious side effect of GLP-1 receptor agonists [2] Signs of severe allergic reaction (anaphylaxis), including difficulty breathing, facial swelling, or widespread rash Symptoms of severe dehydration, such as confusion, dizziness, rapid heartbeat, or inability to keep fluids down Your healthcare provider may wish to review your medication regimen , assess for potential drug interactions, check blood tests (including kidney function, electrolytes, and creatine kinase if muscle breakdown is suspected), and determine whether dose adjustment or alternative treatment is appropriate
This dose is intended to help your body adjust and reduce the risk of side effects that might be unmanageable
The docking results showed that LC had a good binding affinity with AKT1 (binding energy = 5.4 kcal/mol) (Table 3), which was visualized (Figure 6)
